Skip to main content
. 2015 Nov;36(11):2062–2067. doi: 10.3174/ajnr.A4418

Table 1:

Demographic and neuropathologic data of subjects

Case No. Noa Sex Age (yr) PMD (h:min)b DD (yr) MS Type COD
MS
    1 M 80 6:05 45 SPMS Pneumonia
    2 F 81 3:30 27 PPMS Pneumonia
    3 M 75 10:10 50 NA Pneumonia
    4 F 66 7:30 17 NA Pulmonary hypertension
    5 M 71 4:00 15 SPMS Pulmonary carcinoma
    6 F 54 6:00 16 SPMS Liver cancer
    7 M 63 4:30 25 SPMS Pneumonia
    8 M 78 3:00 33 SPMS Euthanasia
    9 M 59 5:00 21 SPMS Euthanasia
    10 M 56 10:10 13 NA Suicide
    11 F 56 8:25 32 SPMS Pneumonia
    12 F 54 3:30 31 SPMS Heart failure
    13 M 58 4:00 27 SPMS Pneumonia
    14 F 95 6:30 55 SPMS Unknown
    15 F 81 6:30 21 SPMS Heart failure
    Mean 68.5 ± 12.7 5:56 ± 2:27 28.5 ± 12.9
Control
    20 4 F 72 >24:00 Myocardial infarct
    21 3 F 58 <24:00 Breast cancer
    22 3 F 76 <24:00 Pneumonia
    23 2 F 76 <8:00 Pneumonia
    Mean 70.5 ± 8.5

Note:—PMD indicates postmortem delay; DD, disease duration since diagnosis; SPMS, secondary-progressive MS; PPMS, primary-progressive MS; COD, cause of death; NA, unavailable/unknown; –, not applicable.

a

The numbers indicate number of hemispheric sections included per case.

b

Control cases are not part of the rapid postmortem examination program and therefore have a longer PMD.